Aim: The high heterogeneity of obsessivecompulsive disorder (OCD) is best described by a multidimensional model involving symptom dimensions. We aimed to investigate white matter alterations associated with OCD, focusing on the impact of long-lasting effect of symptom dimensions assessed at onset of illness. Furthermore, we investigated white matter alterations associated with this disorder, controlling for the impact of medications and for the prevailing current symptom dimension.
Aim: The high heterogeneity of obsessivecompulsive disorder (OCD) is best described by a multidimensional model involving symptom dimensions. We aimed to investigate white matter alterations associated with OCD, focusing on the impact of long-lasting effect of symptom dimensions assessed at onset of illness. Furthermore, we investigated white matter alterations associated with this disorder, controlling for the impact of medications and for the prevailing current symptom dimension.
Methods:
We studied 58 patients affected by OCD and 58 age-and sex-matched healthy controls. We divided patients according to symptom dimension at onset of illness, assessed with the five-factor model. T-tests were performed in order to investigate differences between subgroups. Similar analyses were performed considering the prevailing current symptom dimension. Analyses were conducted with tract-based spatial statistics on diffusion tensor imaging.
Results: Doubt/checking and rituals/superstition symptom dimensions at onset and symmetry/ perfectionism current symptom dimensions were characterized by significant alterations in diffusion tensor imaging measures. An association of white matter alterations and symmetry/perfectionism current dimension was found only when controlling for the effect of doubt/checking dimension at onset. Finally, results pointed out that the observed differences between patients and healthy controls were carried by the effect of previous and current medications.
Conclusion:
Our findings evidenced that onset symptom dimensions are associated with enduring alterations of white matter microstructure. Onset symptom dimensions may reflect underlying endophenotypes. In addition, present results confirm the effect of medications on white matter in OCD, showing a large effect of current treatment on myelination.
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A MAJOR CHALLENGE in the research on obsessive-compulsive disorder (OCD) is understanding its high complexity in phenotypic expression. Patients differ with regard to the content of the obsessions, the compulsion manifestations, the degree of insight into the excessiveness and unreasonableness of the preoccupations and of the associated rituals, the co-occurrence of other psychopathological conditions, and the age of symptoms emergence. [1] [2] [3] In order to reduce this heterogeneity, a multidimensional model of OCD has been proposed. 1 Symptom dimensions have been the most used approach for sorting out OCD heterogeneity. 4, 5 Symptom dimensions have been identified through factor analytic studies of scales investigating obsessive-compulsive (OC) symptomatology. The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) 6 has become the gold standard in OCD symptom investigation and assessment. More than 20 factor analytic studies on the Y-BOCS Symptom Checklist (Y-BOCS-SC) have been carried out to date. Category-level factorial analyses of Y-BOCS-SC (based on 15 a priori categories of the scale) provide a relatively stable model, identifying four factors: (i) symmetry; (ii) forbidden thoughts; (iii) cleaning; and (iv) hoarding. 7 This four-factor model accounts for much of the heterogeneity in OCD symptoms, but it is limited by the fact that individual symptoms have been grouped into predefined Y-BOCS-SC symptom categories and the Y-BOCS-SC 'miscellaneous' obsession and compulsion categories are usually excluded from category-driven analyses. 8 To address this limitation, factor analyses using individual items from the Y-BOCS-SC have been conducted. 8 The largest item-level factorial analysis of the scale carried out to date provides a solution defined by five factors: (i) taboo thoughts; (ii) contamination/cleaning; (iii) doubts; (iv) superstitions/rituals; and (v) symmetry/hoarding. This five-factor model is also supported by heritability patterns, 8 and by the characterization by specific gene variants and brain alterations 9,10 of these dimensions. Classifying by symptom dimension may assist in addressing inconsistent results emerging from genetic research 11 and brain imaging [12] [13] [14] [15] [16] in this disorder. We hypothesize that the 'type of onset' could be predictive of different neural substrates. Only two studies have investigated the impact of symptom dimensions on white matter (WM) organization in adult patients yielding inconsistent results. 17, 18 No study has explored the influence of type of symptomatology at onset on WM microstructure, independently from future development of OC phenotype. We tested our hypothesis analyzing WM integrity alterations in association with the dimension presented by the patient at the emergence of the disorder according to the five-factor model. 8 On the basis of our results, we then investigated the impact of prevailing current symptom dimension in order to further support our findings.
Moreover, we replicated previous findings of the effect of medication on WM microstructure integrity in OCD patients 19 in a larger sample and with a new subgroup, in order to better characterize this effect.
METHODS

Sample characteristics
We recruited 58 subjects (20 women, 38 men) affected by OCD (DSM-IV criteria, SCID-I interview) referring to our hospital unit and 58 healthy controls (HC) matched for age and sex to the OCD sample (Table 1) . Exclusion criteria were: additional psychiatric diagnoses, mental retardation, pregnancy, major medical and neurological disorders, brain lesions, and history of drug or alcohol dependency.
Each subject was provided with a complete description of the study, and gave written informed consent for participation. The study was approved by the local ethical committee (ASL Città di Milano) and it conformed to the provisions of the Declaration of Helsinki.
Thirty-five patients were taking medications at the time of the study (fluvoxamine 60%; clomipramine 25.7%; antipsychotic augmentation of selective serotonin reuptake inhibitors 14.3%), for whom we calculated an index of medication load. 20 Thirteen patients were drug-naïve and 10 patients drug-free (previously medicated patients being free from medications for at least 4 weeks before the magnetic resonance imaging [MRI] acquisition).
Symptom assessment
The Y-BOCS Severity Scale was used to assess symptom severity (range: , while OC symptoms were assessed via the Y-BOCS-SC. Being clinicianrated, this instrument overcame the intrinsic limitations of a self-administered questionnaire, ensuring that reported phenomena and symptoms could be accurately qualified as OC symptoms. Both symptom at OCD onset and main symptom at the moment of MRI acquisition were investigated. The first OC symptom reported by the patients was assessed by the psychiatrist in charge using the best estimation procedure, taking into account case notes and information provided by at least one relative.
After complete symptom assessment, each patient was assigned to one onset dimension and to one current dimension according to the five-symptomdimension model proposed by Katerberg. 8 No patient was assigned to more than one symptom dimension at OCD onset and at MRI acquisition.
Hoarding was not considered in the fifth dimension of Katerberg's model. 21 The obtained subdivisions are presented in Table 2 .
Statistical analyses
All groups were compared with χ 2 independence tests for dichotomous variables, and with one-way analyses of variance followed by Tukey's honestly significant difference post-hoc tests for continuous variables, using SPSS 20 for Windows (SPSS Inc., Chicago, IL, USA).
MRI acquisition
MRI acquisitions were conducted at C.E.R.M.A.C. (Vita-Salute San Raffaele University, Milan, Italy) using a 3-T scanner (Gyroscan Intera, Philips, Best, The Netherlands). Diffusion tensor imaging (DTI) was performed using spin echo-planar imaging and the following parameters: repetition time (TR) echo time (TE) = 8753.89/58 ms, field of view (FOV; mm) 231.43 (ap), 126.50 (fh), 240.00 (rl); acquisition matrix 2.14 × 2.71 × 2.31; 55 contiguous, 2.3-mm thick axial slices reconstructed with in-plane pixel size 1.88 × 1.87 mm; SENSE acceleration factor = 2; 1 b0 and 35 non-collinear directions of the diffusion gradients; and b value = 900 s/mm Data processing and analysis DTI data processing was performed using the FMRIB Software Library (FSL) 5.0 (https://fsl.fmrib.ox.ac. uk/fsl/fslwiki/). 22 Whole-brain differences across groups and correlations with continuous variables were analyzed through tract-based spatial statistics 23 on four diffusion measures of WM integrity: fractional anisotropy (FA), axial (AD), radial (RD), and mean (MD) diffusivity. The processing steps were the same as those in our previous studies. 24, 25 Threshold-free cluster enhancement was used to avoid problems of threshold dependence and smoothing. 26 Voxel-wise levels of significance, corrected for family-wise error multiple comparisons, were calculated with standard permutation testing, 27 and using the 95th percentile of the null distribution to threshold signals at corrected P < 0.05. In order to exclude minor alterations, a threshold of 100 voxels was used.
To test our hypothesis, we used two-sample unpaired t-test across the entire brain, and we investigated:
• Onset symptom dimension -Comparing patients belonging to the same onset dimension against all the other patients for each of the five considered onset dimensions. We accounted for the effects of nuisance covariates known to influence WM microstructure, such as sex, age, 28 age at onset of illness, 29 and medication load.
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• Current symptom dimension -Comparing patients belonging to the same current dimension against all the other patients for each of the considered current dimensions. Age, sex, 28 and age at onset of illness 29 were used as nuisance covariates. Given that the doubt/checking dimension at onset was associated with widespread alterations in WM organization, we replicated the analyses of current symptom dimension adding this variable as a covariate of no-interest, in order to control for its robust effect.
• OCD and medication status -Comparing OCD (currently medicated, drug-free, and drug-naïve) 28 illness duration in years (setting 0 for HC), and education (the groups significantly differed in years of education, even though we did not find an impact of this variable on WM organization).
RESULTS
Demographic and clinical results
No difference was found for the considered clinical and demographic variables between OCD/HC groups divided according to symptom dimensions, or among the OCD subsamples classified for medication status (Table 1) .
No significant association was found across symptom subgroups for age, age at onset, and medication status. We found, however, a significant difference with respect to illness duration: Patients having contamination symptoms at onset of OCD showed a longer illness duration (Table 2) .
DTI analyses Symptom dimensions
We evidenced that two symptom dimensions at onset, doubt/checking and rituals/superstition, and one current symptom dimension, symmetry/perfectionism, were characterized by significant alterations in DTI measures.
Compared to patients belonging to other symptom dimensions, patients having the doubt/checking dimension at onset showed a significant and widespread decrease in AD, involving a large cluster of WM tracts (Table 3 ; Fig. 1 ).
Patients reporting rituals/superstition dimension at onset showed a significant increase in FA in Values of axial diffusivity (means AE SD) are given for the two groups in the white matter regions where a significant difference was present between groups. Dimensions of clusters are expressed in number of voxels (mm (Table 4 ; Fig. 2 ).
Considering the current symptom dimensions, a significant decrease in RD and MD values in association with symmetry/perfectionism was found in several regions of the left hemisphere, only when controlling for the effect of doubt/checking dimension at onset (Fig. 3) . Reduction in RD measure involves two clusters of WM tracts, while reduction of MD involves four clusters (Table 5) .
OCD and medication status OCD patients compared to HC had significantly lower FA values in a widespread region of WM tracts (Table 6 ). A subgroup analysis showed that the difference found between OCD patients and HC is mainly carried by the effect of medication status. Indeed significant differences were found between currently medicated OCD patients and HC, drug-free, and drug-naïve patients. Patients currently taking drugs showed significant reductions in FA values compared to HC and to drug-naïve patients in the same WM tracts where the differences between the whole OCD patients group and controls had been found: genu, body and splenium of corpus callosum (CC), forceps minor, forceps major, bilateral anterior limb of the internal capsule (ALIC), bilateral retrolenticular part of the internal capsule, bilateral external capsule, bilateral anterior radiations (ATR) and posterior thalamic radiations (PTR), bilateral cingulum bundle, bilateral uncinate fasciculus (UF), bilateral inferior longitudinal fasciculus (ILF), bilateral inferior fronto-occipital fasciculus (IFOF), bilateral superior longitudinal fasciculus (SLF), and bilateral middle cerebellar peduncula (Figs 4-5) . Similarly, currently treated patients compared to previously medicated patients being free from medications for at least 4 weeks had a significant reduction in FA in the splenium of CC, left SLF, left ATR, left UF, and left superior Values of fractional anisotropy (means AE SD) are given for the two groups in the white matter regions where a significant difference was present between groups. Dimensions of clusters are expressed in number of voxels (mm 3 ); the point of signal peak is shown, provided in Montreal Neurological Institute coordinates, followed by the indication of the white matter tract involved with maximum likelihood. White matter tracts likely involved in the clusters of significant diffusion tensor imaging measures are shown. corona radiata, and an increase in RD and MD in several WM tracts, including the genu, body, and splenium of CC, bilateral ALIC, bilateral retrolenticular part of the internal capsule, bilateral external capsule, bilateral ATR and PTR, bilateral cingulum bundle, bilateral UF, bilateral ILF, bilateral IFOF, and bilateral SLF.
DISCUSSION Symptom dimensions model
Several studies have shown that distinct neural substrates mediate different symptom dimensions 9, [30] [31] [32] [33] that may therefore be characterized by specific alterations beyond a common pattern of brain 9 However, few diffusion studies have been carried out on this issue 17, 18 and the patterns of WM alterations related to symptom dimensions are far from clear. To our knowledge, this is the first study to investigate retrospectively a possible longlasting effect on WM microstructure of type of symptomatology at onset.
We found that patients having the rituals/superstition dimension at onset of illness have increased FA values in WM tracts corresponding to the corticostriato-thalamo-cortical circuit connections. This finding suggests that this dimension might be associated with a reinforcement of this loop, in turn related to the ritualistic behaviors that characterize this symptom subtype. Furthermore, our study pointed out a widespread reduction of AD in patients with the doubt/checking dimension at onset of the illness. A reduction of AD is associated with axon injuries and dysfunctions. 34 Thus, our results lead us to hypothesize that these axonal alterations can be related to an extensive weakening and/or disorganization of brain connectivity. The continuous checking behaviors lead to metamemory deficits 35 and constantly call into question a subject's perceptions and beliefs. That may correlate with the loosening/disorganization of the feedback and feedforward connections throughout the brain (see Mabbott et al. 36 for a suggestion of the opposite relationship). Furthermore, this finding could support the idea that doubt is the core of OCD, which has been frequently considered the 'disorder of doubt.' 37 Our findings identify a new direction in symptom dimension conceptualization and research, evidencing for the first time the impact of onset symptom dimensions on WM organization. Our results indicate that the modality/symptom dimension with whom the disorder first manifested is associated with long-lasting alterations of WM structure, independently from future development of OC phenotype. This enduring effect might reflect different processes: (i) onset symptom dimensions leave a long-lasting 'scar' on WM structure; or (ii) an underlying endophenotype determines both the emergence of a specific OCD onset dimension and ongoing features of OCD behavior, which result in the observed WM alterations (e.g., 'compulsivity' may constitute an endophenotype of the disorder, which may lead both to the rituals/superstition dimension at onset, and to persistent ritualistic behavior in future OCD expressions, independently from their content).
Analyzing current symptom dimension, our results as well as those of Koch et al. 18 associate the symmetry and/or ordering dimension to an alteration in WM tracts underlying visual processes in both ventral and dorsal routes (although with a difference regarding lateralization), which may be associated with impairments in visuospatial memory. 38 Higher-order visual processing fibers in the left hemisphere are more coherent within patients having predominant symmetry symptoms. It is possible that certain properties of visual stimuli consistently trigger the activation of action representations, 39 resulting in the ordering/arranging compulsive behaviors.
Interestingly, an association of WM alterations and symmetry/perfectionism current dimension was found only when controlling for the effect of the doubt/checking dimension at onset. We consider this result to support the long-lasting effect of symptom dimension at onset independently from future development of OC phenotype. Values of fractional anisotropy (means AE SD) are given for the two groups in the white matter regions where a significant difference was present between groups. Dimensions of clusters are expressed in number of voxels (mm 3 ); the point of signal peak is shown, provided in Montreal Neurological Institute coordinates, followed by the indication of the white matter tract involved with maximum likelihood. White matter tracts likely involved in the clusters of significant diffusion tensor imaging measures are shown.
Future researches should focus on underlying dimensions and endophenotypes to further elucidate the precise mechanism accounting for the evidenced alterations and on WM tracts associated here with OC dimensions in order to better characterize the neural functions involved in specific dimensions.
Effect of drug status
All tract-based spatial statistics studies previously carried out on adult OCD samples have evidenced a reduction in FA in patients compared to controls. 19, 40, 41 These alterations have been shown to be carried by the effect of drug treatment and might constitute a consequence of the pharmacological mechanism of action. 19 The present study confirmed in a larger sample that the significant widespread difference observed between patients and HC is heavily carried by the effect of medications: No difference is found between drug-naïve patients and HC, showing therefore no disorder-specific effects. Instead, we evidenced a strong effect of medications on WM, independently of illness duration, which did not significantly differ between the OCD subgroups and in addition it was used as nuisance covariate in the analyses. Indeed, the FA reductions found in currently treated patients when compared to HC and the drug-naïve group are widespread and the significant WM tracts of the two analyses almost overlap. Such a diffused effect suggests that treatment, and particularly selective serotonin reuptake inhibitors (the first administered medication in our sample), may influence the proliferation of oligodendrocytes and their myelination of axons. 42, 43 It has been recently shown that serotonin adversely affects oligodendrocytes development and myelination; 44 however, in humans no evidence exists yet for a direct neurotransmitter effect.
The alterations shown in currently treated patients decrease when pharmacological treatment is suspended, with a long-lasting effect of previous treatment on WM tracts surrounding the thalamus, which are part of the striato-thalamic circuitry, the core site of neurotransmission dysregulation in OCD. 16, 45 Finally, the increased FA and reduced RD and MD in drug-free patients compared to treated OCD patients lead us to hypothesize that these differences could reveal a remyelination process started with the end of the treatment.
Our findings suggest different short-and longterm mechanisms of drug action on WM microstructure and that medications have a strong influence on WM microstructure, encompassing almost all brain tracts.
Limitations of the study
Finally, some limitations exist in data interpretation given the inherent ambiguity underlying DTI measures, which may be clarified by the convergence of diffusion data with morphometric studies providing an estimate of the number of fibers, 46 or through the use of more complex diffusion models. Another limitation is related to the small size of groups when dividing the different subsamples according to OC dimensions. Moreover, our failure in demonstrating a specific association with most current symptoms is likely related to how the diachronic and synchronic heterogeneity of manifestations is accounted for. The simple consideration of the prevailing symptom dimension is reductive for the investigation of the expression of the disorder. The prevailing symptom dimension at onset was inevitably assessed retrospectively through Y-BOCS. In order to have a congruent assessment of symptom dimensions, we used Y-BOCS for current dimension too. This limitation could be overcome in long-term follow-up studies that assess OC dimension through dimensional scales.
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Conclusions
In conclusion, our findings provide challenging evidence for future research on WM microstructure in OCD, and open new questions regarding the nature of the neurobiological and etiological findings observed to date in this disorder. First, our findings provide support to a multidimensional model of OCD, and indicate that careful attention must be paid to the onset of OC dimensions in order to improve the understanding of the heterogeneity of this disorder. Second, our results suggest that a large effect on the observed differences between patients and HC is dependent on medication status, and possibly on specific mechanisms of action of pharmacological treatments.
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